Bayer AG (BAYN.DE) Initiates Phase 3 Trial Of Xofigo® (Radium Ra 223 Dichloride) Injection In Combination With Abiraterone Acetate For Asymptomatic Or Mildly Symptomatic Chemotherapy-Naive Patients With Bone Predominant Metastatic Castration-Resistant Prostate Cancer
4/2/2014 11:27:45 AM
More...
|
UK Cost Agency Says "No" To Bayer AG (BAYN.DE) Prostate Cancer Drug Xofigo
3/24/2014 7:01:33 AM
More...
|
Ventana Medical Systems, Inc. (VMSI) And Bayer AG (BAYN.DE) Extend Collaboration
3/12/2014 10:22:36 AM
More...
|
Bayer AG (BAYN.DE) To Inject $700 Million In Hemophilia A Drugs
3/11/2014 10:18:37 AM
More...
|
Bayer AG (BAYN.DE) Eyes At Least 7.5 Billion Euros In Sales From Five Key Drugs
2/28/2014 7:25:24 AM
More...
|
Bayer AG (BAYN.DE) Buys Dihon Pharmaceutical Group For About $680 Million To Add Traditional Chinese Medicine To Product Line
2/27/2014 7:48:49 AM
More...
|
Bayer AG (BAYN.DE) Clinches $2.9 Billion Deal For Norway's Algeta
2/24/2014 7:14:33 AM
More...
|
Bayer AG (BAYN.DE) Initiates Phase 3 Trial Of Stivarga® (Regorafenib) Tablets In Patients With Colorectal Cancer After Resection Of Liver Metastases
2/20/2014 9:40:35 AM
More...
|
FDA Rejects Wider Use Of Bayer AG (BAYN.DE)'s Xarelto Drug For Acute Coronary Syndrome
2/14/2014 7:03:39 AM
More...
|
Bayer AG (BAYN.DE) Forms Translational Drug Discovery Collaboration With Peking University
1/9/2014 12:29:53 PM
More...
|
|